Showing results (131-140 of 204) with videos related to

Sort By:
Pageof 21
Journal of Alzheimer'S Disease : JAD|July 18, 2025
Computational screening of repurposed drugs targeting lactoferrin for neurodegenerative diseasesMohammed Alrouji, Mohammed S Alshammari, Fahad Alhumaydhi, et al.
Frontiers in Genetics|February 21, 2025
A structural genomics approach to investigate Dystrophin mutations and their impact on the molecular pathways of Duchenne muscular dystrophyAbdelbaset Mohamed Elasbali, Farah Anjum, Osama A AlKhamees, et al.
International Journal of Biological Macromolecules|January 4, 2024
Identifying repurposed drugs as potential inhibitors of Apolipoprotein E: A bioinformatics approach to target complex diseases associated with lipid metabolism and neurodegenerationMohammad Furkan, Mohd Shahnawaz Khan, Moyad Shahwan, et al.
Journal of Biomolecular Structure & Dynamics|August 4, 2022
A multi-spectroscopic and computational simulations study to delineate the interaction between antimalarial drug hydroxychloroquine and human serum albuminKashish Azeem, Mofieed Ahmed, Taj Mohammad, et al.
ACS Omega|March 29, 2021
Multispectroscopic and Molecular Docking Insight into Elucidating the Interaction of Irisin with Rivastigmine Tartrate: A Combinational Therapy Approach to Fight Alzheimer's DiseaseRashid Waseem, Anas Shamsi, Taj Mohammad, et al.
Journal of Biomolecular Structure & Dynamics|May 31, 2023
Structure-guided identification of potent inhibitors of ROS1 kinase for therapeutic development against non-small cell lung cancerMohd Shahnawaz Khan, Nojood Altwaijry, Moneera Saud Al-Bagmi, et al.
Molecular Diversity|September 20, 2023
Identifying β-secretase 1 (BACE1) inhibitors from plant-based compounds: an approach targeting Alzheimer's therapeutics employing molecular docking and dynamics simulationMohammed Alrouji, Fahad A Alhumaydhi, Waleed Al Abdulmonem, et al.
Frontiers in Pharmacology|November 29, 2024
Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditionsMohammed Alrouji, Kumar Venkatesan, Mohammed S Alshammari, et al.
Frontiers in Pharmacology|May 27, 2024
Comprehensive spectroscopic and computational insight into the binding of vanillin with human transferrin: targeting neuroinflammation in Alzheimer's disease therapeuticsMohammed Alrouji, Sabina Yasmin, Fahad A Alhumaydhi, et al.
International Journal of Biological Macromolecules|March 7, 2024
Exploring therapeutic potential of Rutin by investigating its cyclin-dependent kinase 6 inhibitory activity and binding affinityMohd Yousuf, Shama Khan, Afzal Hussain, et al.
Pageof 21